Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.

about

The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs.Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial.

P2860

Q40296327-CBDAD708-402C-4DF5-B1AD-4392D184F94F Q53080229-DDE98628-7BA5-48A3-9D7C-BAD8F4BF5A7D

P2860

Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.

Item

http://www.wikidata.org/entity/Q40528471

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Recovery of antigen-specific T ...... sociated TLR-agonist adjuvant.

@en

type

Item

label

Recovery of antigen-specific T ...... sociated TLR-agonist adjuvant.

@en

prefLabel

Recovery of antigen-specific T ...... sociated TLR-agonist adjuvant.

@en

P1476

Recovery of antigen-specific T ...... ssociated TLR-agonist adjuvant

@en

P2093

Angela J Toepp

http://www.w3.org/2001/XMLSchema#string

Kevin J Esch

http://www.w3.org/2001/XMLSchema#string

Randall F Howard

http://www.w3.org/2001/XMLSchema#string

P2860

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

Leishmaniasis worldwide and global estimates of its incidence

Canine visceral leishmaniasis, United States and Canada, 2000-2003

Leishmaniasis impact and treatment access

Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background

Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis

Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

P304

5225-5234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2016.09.016

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27665354

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

5053902

http://www.w3.org/2001/XMLSchema#string

Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.

about

P2860

P2860

Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932